标题
Iron as a therapeutic target for Parkinson's disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 33, Issue 4, Pages 568-574
出版商
Wiley
发表日期
2018-01-30
DOI
10.1002/mds.27275
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- In vivodetection of lateral-ventral tier nigral degeneration in Parkinson's disease
- (2017) Daniel E. Huddleston et al. HUMAN BRAIN MAPPING
- Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care
- (2017) Yi Wang et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
- (2017) James A. Duce et al. Molecular Neurodegeneration
- Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease
- (2017) Philipp Mahlknecht et al. MOVEMENT DISORDERS
- The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition
- (2017) Kuo-Chen Wu et al. NEUROBIOLOGY OF DISEASE
- Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation
- (2017) Eleonora Carboni et al. NEUROMOLECULAR MEDICINE
- Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
- (2017) Antonio Martin-Bastida et al. Scientific Reports
- Iron and dopamine: a toxic couple
- (2016) Dominic J. Hare et al. BRAIN
- The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease
- (2016) Julio Acosta-Cabronero et al. BRAIN
- Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
- (2016) Abdel A. Belaidi et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of ATP13A2 via PHD2-HIF1 Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease
- (2016) S. Rajagopalan et al. JOURNAL OF NEUROSCIENCE
- Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
- (2016) Bruce Do Van et al. NEUROBIOLOGY OF DISEASE
- Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
- (2016) Lucie Hopes et al. PLoS One
- Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice
- (2016) Pavle Matak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements
- (2016) Jian-Yong Wang et al. Scientific Reports
- Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice
- (2015) David I. Finkelstein et al. ACS Chemical Neuroscience
- Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of -Amyloid Precursor Protein
- (2015) S. Ayton et al. JOURNAL OF NEUROSCIENCE
- Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators
- (2015) David G. Workman et al. Metallomics
- Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse
- (2015) Peng Lei et al. NEUROBIOLOGY OF DISEASE
- Usefulness of SWI for the Detection of Iron in the Motor Cortex in Amyotrophic Lateral Sclerosis
- (2014) Yuko Adachi et al. JOURNAL OF NEUROIMAGING
- The role of iron in brain ageing and neurodegenerative disorders
- (2014) Roberta J Ward et al. LANCET NEUROLOGY
- Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
- (2014) Jose Pedro Friedmann Angeli et al. NATURE CELL BIOLOGY
- Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
- (2013) David Devos et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
- (2013) Orly Weinreb et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin
- (2013) Shannon L. Rhodes et al. NEUROBIOLOGY OF DISEASE
- Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease
- (2013) Nico Bunzeck et al. PARKINSONISM & RELATED DISORDERS
- Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up
- (2013) Miguel Ulla et al. PLoS One
- Regional siderosis: a new challenge for iron chelation therapy
- (2013) Zvi Ioav Cabantchik et al. Frontiers in Pharmacology
- Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
- (2012) Scott Ayton et al. ANNALS OF NEUROLOGY
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Changing iron content of the mouse brain during development
- (2012) Gregory P. Holmes-Hampton et al. Metallomics
- Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
- (2012) Peng Lei et al. NATURE MEDICINE
- Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
- (2010) Jaime N. Guzman et al. NATURE
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
- (2008) J. Salazar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now